TY - JOUR AU - Chade, D. C. AU - Shariat, S. F. AU - Godoy, G. AU - Savage, C. J. AU - Cronin, A. M. AU - Bochner, B. H. AU - Donat, S. M. AU - Herr, H. W. AU - Dalbagni, G. PY - 2010 DA - 2010// TI - Clinical outcomes of primary bladder carcinoma in situ in a contemporary series JO - J Urol VL - 184 UR - https://doi.org/10.1016/j.juro.2010.03.032 DO - 10.1016/j.juro.2010.03.032 ID - Chade2010 ER - TY - JOUR AU - Bosch, S. AU - Alfred Witjes, J. PY - 2011 DA - 2011// TI - Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review JO - Eur Urol VL - 60 UR - https://doi.org/10.1016/j.eururo.2011.05.045 DO - 10.1016/j.eururo.2011.05.045 ID - Bosch2011 ER - TY - JOUR AU - Zieger, K. AU - Jensen, K. M. PY - 2011 DA - 2011// TI - Long-term risk of progression of carcinoma in situ of the bladder and impact of bacille Calmette-Guérin immunotherapy on the outcome JO - Scand J Urol Nephrol VL - 45 UR - https://doi.org/10.3109/00365599.2011.599335 DO - 10.3109/00365599.2011.599335 ID - Zieger2011 ER - TY - JOUR AU - Nese, N. AU - Gupta, R. AU - Bui, M. H. AU - Amin, M. B. PY - 2009 DA - 2009// TI - Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis JO - J Natl Compr Cancer Netw VL - 7 UR - https://doi.org/10.6004/jnccn.2009.0004 DO - 10.6004/jnccn.2009.0004 ID - Nese2009 ER - TY - JOUR AU - Lamm, D. L. AU - Blumenstein, B. A. AU - Crissman, J. D. AU - Montie, J. E. AU - Gottesman, J. E. AU - Lowe, B. A. AU - Sarosdy, M. F. AU - Bohl, R. D. AU - Grossman, H. B. AU - Beck, T. M. AU - Leimert, J. T. AU - Crawford, E. D. PY - 2000 DA - 2000// TI - Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized southwest oncology group study JO - J Urol VL - 163 UR - https://doi.org/10.1016/S0022-5347(05)67707-5 DO - 10.1016/S0022-5347(05)67707-5 ID - Lamm2000 ER - TY - JOUR AU - Casey, R. G. AU - Catto, J. W. AU - Cheng, L. AU - Cookson, M. S. AU - Herr, H. AU - Shariat, S. AU - Witjes, J. A. AU - Black, P. C. PY - 2015 DA - 2015// TI - Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review JO - Eur Urol VL - 67 UR - https://doi.org/10.1016/j.eururo.2014.10.040 DO - 10.1016/j.eururo.2014.10.040 ID - Casey2015 ER - TY - JOUR AU - Asgari, M. AU - Nabi Maybodi, M. AU - Abolhasani, M. PY - 2016 DA - 2016// TI - Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: analysis of CK20, CD44, P53 and Ki67 JO - Med J Islam Repub Iran VL - 30 ID - Asgari2016 ER - TY - JOUR AU - Jung, S. AU - Wu, C. AU - Eslami, Z. AU - Tanguay, S. AU - Aprikian, A. AU - Kassouf, W. AU - Brimo, F. PY - 2014 DA - 2014// TI - The role of immunohistochemistry in the diagnosis of flat urothelial lesions: a study using CK20, CK5/6, P53, Cd138, and Her2/Neu JO - Ann Diagn Pathol VL - 18 UR - https://doi.org/10.1016/j.anndiagpath.2013.10.006 DO - 10.1016/j.anndiagpath.2013.10.006 ID - Jung2014 ER - TY - JOUR AU - Edgecombe, A. AU - Nguyen, B. N. AU - Djordjevic, B. AU - Belanger, E. C. AU - Mai, K. T. PY - 2012 DA - 2012// TI - Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia JO - Appl Immunohistochem Mol Morphol VL - 20 UR - https://doi.org/10.1097/PAI.0b013e3182351ed3 DO - 10.1097/PAI.0b013e3182351ed3 ID - Edgecombe2012 ER - TY - JOUR AU - Yin, H. AU - He, Q. AU - Li, T. AU - Leong, A. S. PY - 2006 DA - 2006// TI - Cytokeratin 20 and Ki-67 to distinguish carcinoma in situ from flat non-neoplastic urothelium JO - Appl Immunohistochem Mol Morphol VL - 14 UR - https://doi.org/10.1097/00129039-200609000-00002 DO - 10.1097/00129039-200609000-00002 ID - Yin2006 ER - TY - JOUR AU - Kunju, L. P. AU - Lee, C. T. AU - Montie, J. AU - Shah, R. B. PY - 2005 DA - 2005// TI - Utility of cytokeratin 20 and Ki-67 as markers of urothelial dysplasia JO - Pathol Int VL - 55 UR - https://doi.org/10.1111/j.1440-1827.2005.01821.x DO - 10.1111/j.1440-1827.2005.01821.x ID - Kunju2005 ER - TY - JOUR AU - Mallofré, C. AU - Castillo, M. AU - Morente, V. AU - Solé, M. PY - 2003 DA - 2003// TI - Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia JO - Mod Pathol VL - 16 UR - https://doi.org/10.1097/01.MP.0000056628.38714.5D DO - 10.1097/01.MP.0000056628.38714.5D ID - Mallofré2003 ER - TY - JOUR AU - McKenney, J. K. AU - Desai, S. AU - Cohen, C. AU - Amin, M. B. PY - 2001 DA - 2001// TI - Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens JO - Am J Surg Pathol VL - 25 UR - https://doi.org/10.1097/00000478-200108000-00013 DO - 10.1097/00000478-200108000-00013 ID - McKenney2001 ER - TY - JOUR AU - Arias-Stella, J. a. v. i. e. r. A. AU - Shah, A. l. p. a. B. AU - Gupta, N. i. l. e. s. h. S. AU - Williamson, S. e. a. n. R. PY - 2018 DA - 2018// TI - CK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens With Equivocal Atypia JO - Archives of Pathology & Laboratory Medicine VL - 142 UR - https://doi.org/10.5858/arpa.2016-0411-OA DO - 10.5858/arpa.2016-0411-OA ID - Arias-Stella2018 ER - TY - JOUR AU - Zhou, M. AU - Chinnaiyan, A. M. AU - Kleer, C. G. AU - Lucas, P. C. AU - Rubin, M. A. PY - 2002 DA - 2002// TI - Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions JO - Am J Surg Pathol VL - 26 UR - https://doi.org/10.1097/00000478-200207000-00012 DO - 10.1097/00000478-200207000-00012 ID - Zhou2002 ER - TY - JOUR AU - Gunia, S. AU - May, M. AU - Scholmann, K. AU - Störkel, S. AU - Hoschke, B. AU - Koch, S. AU - Dietel, M. AU - Kristiansen, G. PY - 2008 DA - 2008// TI - Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer JO - Virchows Arch VL - 453 UR - https://doi.org/10.1007/s00428-008-0638-1 DO - 10.1007/s00428-008-0638-1 ID - Gunia2008 ER - TY - JOUR AU - Jiang, Z. AU - Fanger, G. R. AU - Woda, B. A. AU - Banner, B. F. AU - Algate, P. AU - Dresser, K. AU - Xu, J. AU - Chu, P. G. PY - 2003 DA - 2003// TI - Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases JO - Hum Pathol VL - 34 UR - https://doi.org/10.1016/S0046-8177(03)00268-5 DO - 10.1016/S0046-8177(03)00268-5 ID - Jiang2003 ER - TY - JOUR AU - Langner, C. AU - Rupar, G. AU - Leibl, S. AU - Hutterer, G. AU - Chromecki, T. AU - Hoefler, G. AU - Rehak, P. AU - Zigeuner, R. PY - 2005 DA - 2005// TI - Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression JO - Virchows Arch VL - 448 UR - https://doi.org/10.1007/s00428-005-0129-6 DO - 10.1007/s00428-005-0129-6 ID - Langner2005 ER - TY - JOUR AU - Aron, M. AU - Luthringer, D. J. AU - McKenney, J. K. AU - Hansel, D. E. AU - Westfall, D. E. AU - Parakh, R. AU - Mohanty, S. K. AU - Balzer, B. AU - Amin, M. B. PY - 2013 DA - 2013// TI - Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia JO - Am J Surg Pathol VL - 37 UR - https://doi.org/10.1097/PAS.0000000000000114 DO - 10.1097/PAS.0000000000000114 ID - Aron2013 ER - TY - JOUR AU - Fellegara, G. AU - Gabba, S. AU - Dorji, T. AU - Luca, G. AU - Colecchia, M. PY - 2014 DA - 2014// TI - Observations on Aron et al's "utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3 CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinoma in situ (CIS) and reactive urothelial atypia" JO - Am J Surg Pathol VL - 38 UR - https://doi.org/10.1097/PAS.0000000000000191 DO - 10.1097/PAS.0000000000000191 ID - Fellegara2014 ER -